Petrillo, Marco
 Distribuzione geografica
Continente #
NA - Nord America 2.452
EU - Europa 2.303
AS - Asia 1.799
SA - Sud America 352
AF - Africa 58
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 4
AN - Antartide 1
Totale 6.977
Nazione #
US - Stati Uniti d'America 2.394
DE - Germania 959
SG - Singapore 915
CN - Cina 469
SE - Svezia 349
BR - Brasile 292
IT - Italia 170
UA - Ucraina 160
FR - Francia 151
GB - Regno Unito 117
IE - Irlanda 100
PL - Polonia 90
VN - Vietnam 83
IN - India 78
ID - Indonesia 65
RU - Federazione Russa 64
FI - Finlandia 53
TR - Turchia 46
CA - Canada 29
AR - Argentina 22
BE - Belgio 20
HK - Hong Kong 17
IQ - Iraq 17
MX - Messico 17
BD - Bangladesh 16
CI - Costa d'Avorio 15
ZA - Sudafrica 13
UZ - Uzbekistan 11
EC - Ecuador 10
ES - Italia 10
MA - Marocco 10
SA - Arabia Saudita 10
IR - Iran 9
NL - Olanda 9
KE - Kenya 7
CH - Svizzera 6
CL - Cile 6
JP - Giappone 6
KZ - Kazakistan 6
PE - Perù 6
PY - Paraguay 6
AT - Austria 5
KR - Corea 5
PH - Filippine 5
PK - Pakistan 5
VE - Venezuela 5
AU - Australia 4
EG - Egitto 4
LT - Lituania 4
LV - Lettonia 4
NO - Norvegia 4
TJ - Tagikistan 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
EU - Europa 3
IL - Israele 3
JM - Giamaica 3
JO - Giordania 3
NP - Nepal 3
NZ - Nuova Zelanda 3
PA - Panama 3
TN - Tunisia 3
UY - Uruguay 3
AL - Albania 2
AM - Armenia 2
AZ - Azerbaigian 2
BH - Bahrain 2
BY - Bielorussia 2
CY - Cipro 2
CZ - Repubblica Ceca 2
GE - Georgia 2
GR - Grecia 2
IS - Islanda 2
KG - Kirghizistan 2
LU - Lussemburgo 2
MY - Malesia 2
NG - Nigeria 2
PT - Portogallo 2
RO - Romania 2
A1 - Anonimo 1
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
CO - Colombia 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LI - Liechtenstein 1
LK - Sri Lanka 1
MD - Moldavia 1
ME - Montenegro 1
NC - Nuova Caledonia 1
Totale 6.968
Città #
Chandler 568
Singapore 465
Ashburn 202
Jacksonville 117
Beijing 104
Dublin 100
San Mateo 100
Warsaw 79
New York 75
Nürnberg 74
Wilmington 73
Nanjing 72
Ann Arbor 66
Los Angeles 66
Jakarta 62
Dearborn 51
Marseille 47
Boston 45
Houston 37
Cattolica 35
Izmir 35
Munich 32
Moscow 30
Lawrence 29
São Paulo 28
Princeton 27
Buffalo 26
Dallas 26
Frankfurt am Main 24
Hanoi 23
Seattle 23
Ho Chi Minh City 22
Brussels 20
Hangzhou 20
Redwood City 20
Chicago 18
Hefei 17
Kunming 17
Rome 17
Boardman 16
Lancaster 16
Abidjan 15
Fairfield 15
Mountain View 15
Changsha 14
Helsinki 14
Hong Kong 14
Nanchang 14
Norwalk 14
Milan 13
Tianjin 13
Woodbridge 13
Bremen 12
Hebei 12
Leawood 12
London 12
Shenyang 12
University Park 12
Tashkent 11
Brooklyn 10
Atlanta 9
Detroit 9
Düsseldorf 9
Falls Church 9
Guangzhou 9
Phoenix 9
Belo Horizonte 8
Brasília 8
Denver 8
Redmond 8
Bucchianico 7
Hyderabad 7
Jiaxing 7
Johannesburg 7
Manchester 7
Montreal 7
Nuremberg 7
Orem 7
Toronto 7
Edinburgh 6
Haiphong 6
Jinan 6
Lima 6
Quito 6
Rio de Janeiro 6
Stockholm 6
Wroclaw 6
Wuhan 6
Amsterdam 5
Augusta 5
Baghdad 5
Chennai 5
Curitiba 5
Istanbul 5
Lauterbourg 5
Millbury 5
Mumbai 5
Nairobi 5
Newark 5
Ottawa 5
Totale 3.434
Nome #
Prognostic role of topoisomerase-IIalpha in advanced ovarian cancer patients 284
Evaluation of quality of life and emotional distress in endometrial cancer patients: A 2-year prospective, longitudinal study 220
Paclitaxel, epirubicin, and cisplatin (TEP) regimen as neoadjuvant treatment in locally advanced cervical cancer: long-term results 210
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery 204
BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study 175
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 170
Prognostic role of Ca125 response criteria and RECIST criteria: analysis of results from the MITO-3 phase III trial of gemcitabine versus pegylated liposomal doxorubicin in recurrent ovarian cancer. 169
Quality of life and psychological distress in locally advanced cervical cancer patients administered pre-operative chemoradiotherapy 168
Secondary cytoreductive surgery in patients with isolated platinum-resistant recurrent ovarian cancer: A retrospective analysis 167
Influence of Intraperitoneal Dissemination Assessed by Laparoscopy on Prognosis of Advanced Ovarian Cancer: An Exploratory Analysis of a Single-Institution Experience 162
Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation? 157
A complete pathological response to treatment in a young patient with locally advanced minimal deviation adenocarcinoma of the uterine cervix undergoing chemoradiation followed by radical surgery 150
Incidence and predictive factors for complications after uterine leiomyoma embolization 148
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 143
Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: a prospective, longitudinal study 142
Secondary malignancies of the uterine cervix: a potential diagnostic pitfall 140
Prognostic role of the recepteur d'origine nantais (RON) expression in ovarian cancer patients 135
Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: a retrospective longitudinal analysis using matched tumor biopsie 135
Non-catalytic region of tyrosine kinase adaptor protein 2 (NCK2) pathways as factor promoting aggressiveness in ovarian cancer 131
Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: A case-control study on survival in patients with two year follow-up 127
Impact of bevacizumab containing first line chemotherapy on recurrent disease in epithelial ovarian cancer: A case-control study 127
Minimally invasive versus standard laparotomic interval debulking surgery in ovarian neoplasm: A single-institution retrospective case-control study 126
Long-term prospective longitudinal evaluation of emotional distress and quality of life in cervical cancer patients who remained disease-free 2-years from diagnosis 123
The relevance of prelamin A and RAD51 as molecular biomarkers in cervical cancer 123
Preoperative serum human epididymis protein 4 levels in early stage endometrial cancer: A prospective study 119
Mutational status of KRAS, NRAS, and BRAF in primary clear cell ovarian carcinoma 118
Identification and antitumor activity of a novel inhibitor of the NIMA-related kinase NEK6 117
Fertility-sparing surgery in ovarian cancer extended beyond the ovaries: a case report and review of the literature 114
Targeting the hallmarks of ovarian cancer: The big picture 114
Preoperative Anti-Class III β-Tubulin Antibodies As Relevant Clinical Biomarkers in Ovarian Cancer 113
A combined ANXA2-NDRG1-STAT1 gene signature predicts response to chemoradiotherapy in cervical cancer 112
Pathologic response to neoadjuvant chemotherapy in advanced ovarian cancer: utility of a scoring system to predict outcomes 112
Laparoscopic En Bloc Right Diaphragmatic Peritonectomy for Diaphragmatic Endometriosis According to the Sugarbaker Technique 111
Characteristics and patterns of care of endometrial cancer before and during COVID-19 pandemic 108
FOXL2 molecular status in adult granulosa cell tumors of the ovary: A study of primary and metastatic cases 105
Ovarian low and high grade serous carcinomas: hidden divergent features in the tumor microenvironment 105
Uncovering the role of nuclear Lysyl oxidase (LOX) in advanced high grade serous ovarian cancer 105
Time trade-off procedure for measuring health utilities loss with human papillomavirus-induced diseases: a multicenter, retrospective, observational pilot study in Italy 104
Robotic Versus Laparoscopic Staging for Early Ovarian Cancer: A Case Matched Control Study 97
Polarisation of Tumor-Associated Macrophages toward M2 Phenotype Correlates with Poor Response to Chemoradiation and Reduced Survival in Patients with Locally Advanced Cervical Cancer. 95
Robotic Total Mesometrial Resection versus Laparoscopic Total Mesometrial Resection in Early Cervical Cancer: A Case-Control Study 95
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts 94
Restructuring surgical training after COVID-19 pandemic: A nationwide survey on the Italian scenario on behalf of the Italian polyspecialistic young surgeons society (SPIGC) 90
Survivin protein as predictor of pathologic response in patients with locally advanced cervical cancer treated with chemoradiation followed by radical surgery 88
Secondary cytoreduction in ovarian cancer: who really benefits? 88
Self-Reported Long-Term Autonomic Function After Laparoscopic Total Mesometrial Resection for Early-Stage Cervical Cancer: A Multicentric Study 87
Incidence, predictors and clinical outcome of pancreatic fistula in patients receiving splenectomy for advanced or recurrent ovarian cancer: a large multicentric experience 84
Neoadjuvant Chemotherapy Followed by Maintenance Therapy With or Without Bevacizumab in Unresectable High-Grade Serous Ovarian Cancer: A Case-Control Study 83
Laparoscopic laterally extended endopelvic resection procedure for gynecological malignancies 82
Systematic Review of Cytoreductive Surgery and Bevacizumab-Containing Chemotherapy in Advanced Ovarian Cancer: Focus on Safety 78
Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: a retrospective longitudinal analysis using matched tumor biopsies 77
The safety of bevazicumab for the treatment of ovarian cancer 77
Role of extracellular vesicles in epithelial ovarian cancer: A systematic review 77
Patterns of Lymph Node Metastases in Apparent Stage I Low-Grade Epithelial Ovarian Cancer: A Multicenter Study 71
Long-Term Survival for Platinum-Sensitive Recurrent Ovarian Cancer Patients Treated with Secondary Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (HIPEC) 69
Pharmacokinetics of cisplatin during open and minimally-invasive secondary cytoreductive surgery plus HIPEC in women with platinum-sensitive recurrent ovarian cancer: a prospective study 68
Cytoreductive surgery plus platinum-based hyperthermic intraperitoneal chemotherapy in epithelial ovarian cancer: A promising integrated approach to improve locoregional control 66
RE: Pattern of and reason for postoperative residual disease in patients with advanced ovarian cancer following upfront radical debulking surgery 63
Role of CTGF in Sensitivity to Hyperthermia in Ovarian and Uterine Cancers 30
Simple hysterectomy versus radical hysterectomy in early-stage cervical cancer: A systematic review and meta-analysis 15
Sentinel node mapping, sentinel node mapping plus back-up lymphadenectomy, and lymphadenectomy in Early-sTage cERvical caNcer scheduled for fertilItY-sparing approach: The ETERNITY project 9
Totale 7.076
Categoria #
all - tutte 28.352
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.352


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021214 0 0 0 0 0 15 48 9 41 19 73 9
2021/2022618 52 25 11 43 35 25 10 98 40 57 92 130
2022/20231.263 154 203 118 225 53 171 66 75 141 11 28 18
2023/2024500 28 142 8 22 11 73 41 13 9 30 59 64
2024/20251.006 25 26 85 45 105 43 21 36 177 81 190 172
2025/20261.522 398 69 104 260 597 94 0 0 0 0 0 0
Totale 7.076